Published August 22, 2026
This one came across our desk from a news source on 2026-09-02 — 'FDA warnings on gastroparesis and ileus: the food-side…'. Our job here is the translation layer: what the headline means in protein, fiber and fat terms, and what stays unchanged on your plate no matter what the news says.
Side-effect reporting drives most GLP-1 searches — nausea and constipation lead the list. The food variables behind both are fat (for nausea) and fiber plus water (for constipation), which is what the site's scoring model encodes. A news story about side effects is usually a story about the two variables this site ranks foods on.
What ties GLP-1 coverage together is a small set of food variables that keep resurfacing: protein protects the muscle you want to keep, fat is the strongest predictor of nausea on a slowed stomach, and fiber plus water manages constipation. This site's verdict system was built around those three because they are the ones that actually move outcomes.
Whatever the angle of the story — heart, kidney, muscle, side effects — the practical food response is remarkably consistent. That consistency is deliberate: the verdict labels are a fixed reference, so a reader does not need the news to know what to eat on any given day.
A clear boundary keeps this site useful: it answers what is in the food, and it stops there. Whether a headline applies to your dose or your treatment is a question for your clinician — this post says that explicitly rather than blurring the line.
We cover a story when it is recent, sourced, and relevant to people who eat on a GLP-1. Unlinked rumors never make it to a page, because the site's whole method is traceability — applied to news the same way it is applied to food values.
The practical read of this story is simple: low-fat for nausea, fiber plus water for constipation.
The plate does not change with the headline: protein anchors, vegetables fill, heavy food is portioned, water is constant.
Side-effect stories point to the two food levers — lower fat for nausea, more fiber plus water for constipation; outcome stories point to the same plate, day after day.
A headline is not a prescription: questions about your own dose or symptoms belong with your healthcare provider.
Think of the week as a ledger: a few heavy entries and a few light ones still balance if the structure holds. That is the frame the site recommends. A single plate proves nothing; a week of plates shows the actual pattern.
is the whole method in practice: protein first, produce filling, rich quarter small. The foods rotate; the shape does not. The frame is the deliverable; the fillings can change with the season.
This site's role stops at the food column: what is in the food, how it scores, and which pattern usually works. The clinical column — dose, diagnosis, treatment — belongs to your provider. When the food-side pattern stops holding, the boundary says the next step is not another table but a conversation with the person managing your treatment. That division of labor is the cleanest way to keep a food site useful without pretending to be a clinic.
Relevance is mostly indirect: a study changes which nutrient gets attention, not the food pattern itself. The pattern — protein first, portions small, fiber and water constant — survives every headline, and the published method stays the reference for whichever nutrient the story highlights. Your dose and treatment questions remain your clinician's job.
A single story is not a reason to change what you eat. The verdicts rest on USDA values and published guideline frameworks, and those do not move with the news cycle — a study may refine the framework eventually, but one headline does not change the per-100g numbers. The stable response is the stable plate: protein first, vegetables, small servings, water.
The checklist is short: is there a named source, a date, and a study or agency behind it? FDA, peer-reviewed journals and established health media clear the bar; headlines with no link and no study do not. Watch for single-trial overreach too. This post links its source openly, which is the standard we apply to ourselves.
Once a week is plenty for most people — the food pattern barely changes from headline to headline, and the site's verdicts are a stable reference. Daily checking mostly adds noise. When a headline genuinely affects your own medication or dose, that is the moment to involve your clinician rather than the news cycle.
Source: a news source · 2026-09-02. The source is named and linked; the analysis is limited to what the food data can speak to.
Readers who open the linked pages will find the same scoring screen running everywhere. The post ends at the food line, the same line every page on the site draws.
The guarantee is simple: the same screen scored this page that scored every other page on the site, and it will score the next one the same way. USDA values in, three questions applied, veto flags checked, a label assigned, and the sources named. That consistency is what makes 7,700+ verdicts comparable to each other and trustworthy over time. It is also what lets the archive grow without the advice drifting — a reader who knows the method can predict the verdicts, and a reader who wants to check can reproduce them. Boring consistency is the feature.
We follow the GLP-1 news the way we follow food data: note the source, check the claims, and write only what c
Tirzepatide can make the birth-control pill less reliable…A quick note before the analysis: this post is not a summary of the study, and it is not medical commentary. &
Next-gen GLP-1s outperform Mounjaro: 38-trial analysis puts…This one came across our desk from Annals of Internal Medicine network meta-analysis via AOL (Aug 2026) on 202